Advertisement

Preoperative Work-up: PET and PET-CT

  • Valentina Ambrosini
  • Maria Cristina Marzola
  • Paola Caroli
  • Stefano Fanti
  • Domenico Rubello
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

Esophageal cancer is characterized by an overall poor prognosis. Due to late onset of symptoms and early metastatic spread, only about 15–20% of patients undergo curative resection [1]. Accurate staging in esophageal squamous cell carcinoma (SCC) is essential to decide the correct therapeutic strategy. Currently, a limited number of patients are candidates for curative resection while in those with advanced-stage disease a combination of neoadjuvant chemotherapy and/or radiotherapy followed by surgery is recommended.

Keywords

Positron Emission Tomography Squamous Cell Carcinoma Esophageal Cancer Esophageal Squamous Cell Carcinoma Curative Resection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Falk GW (2009) Risk factors for esophageal cancer development. Surg Oncol Clin N Am 18:469–85PubMedCrossRefGoogle Scholar
  2. 2.
    Harewood GC, Wiersema MJ (2002) A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer. Am J Gastroenterol 97:452–458PubMedCrossRefGoogle Scholar
  3. 3.
    van Westreenen HL, Westerterp M, Bossuyt PM et al (2004) Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22:3805–3812PubMedCrossRefGoogle Scholar
  4. 4.
    Flamen P (2004) Positron emission tomography in gastric and esophageal cancer. Curr Opin Oncol 16:359–363PubMedCrossRefGoogle Scholar
  5. 5.
    Heeren PA, Jager PL, Bongaerts F et al (2004) Detection of distant metastases in esophageal cancer with (18)F-FDG PET. J Nucl Med 45:980–987PubMedGoogle Scholar
  6. 6.
    Gananadha S, Hazebroek EJ, Leibman S et al (2008) The utility of FDG-PET in the preoperative staging of esophageal cancer. Dis Esoph 21:389–394CrossRefGoogle Scholar
  7. 7.
    Salahudeen HM, Balan A, Naik K et al (2008) Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma Clinical Radiol 63:765–773Google Scholar
  8. 8.
    Walker AJ, Spier BJ, Perlman SB et al (2011) Integrated PET-CT fusion imaging and endoscopic ultrasound in the pre-operative staging and evaluation of esophageal cancer. Mol Imaging Biol 13:166–171PubMedCrossRefGoogle Scholar
  9. 9.
    Chuang HH, Macapinlac HA (2009) The evolving role of PET-CT in the management of esophageal cancer. Q J Nucl Med Mol Imaging 53:201–209PubMedGoogle Scholar
  10. 10.
    Schreurs LM, Janssens AC, Groen H et al (2011) Value of EUS in determining curative resectability in reference to CT and FDG-PET: the optimal sequence in preoperative staging of esophageal cancer? Ann Surg Oncol. Epub ahead of printGoogle Scholar
  11. 11.
    van Westreenen HL, Westerterp M, Bossuyt PM et al (2004) Systematic review of the staging performance of 18F-fuorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22:3805–3812PubMedCrossRefGoogle Scholar
  12. 12.
    Kato H, Miyazaki T, Nakajima M et al (2005) The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 103:148–156PubMedCrossRefGoogle Scholar
  13. 13.
    van Vliet EP, Heijenbrok-Kal MH, Hunink MG et al (2008) Staging investigations for oesophageal cancer: a meta-analysis Br J Cancer 98:547–557Google Scholar
  14. 14.
    Lowe VJ, Booya F, Fletcher JG et al (2005) Comparison of positron emission tomography, computed tomography and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 7:422–430PubMedCrossRefGoogle Scholar
  15. 15.
    Thurau K, Palmes D, Franzius C (2011) Impact of PET-CT on primary staging and response control on multimodal treatment of esophageal cancer. World J Surg 35:608–616PubMedCrossRefGoogle Scholar
  16. 16.
    Noble F, Bailey D, Tung K, Byrne JP (2009) Impact of integrated PET-CT in the staging of oesophageal cancer: a UK population based cohort study. Clin Radiol 64:699–705PubMedCrossRefGoogle Scholar
  17. 17.
    Gillies RS, Middleton MR, Maynard ND et al (2011) Additional benefit of a-F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer. Eur Radiol 21:274–280PubMedCrossRefGoogle Scholar
  18. 18.
    van Westreenen HL, Plukker JT, Cobben DC et al (2005) Prognostic value of the standardized uptake value in esophageal cancer. AJR Am J Roentgenol 185:436–440PubMedCrossRefGoogle Scholar
  19. 19.
    Hong D, Lunagomez S, Kim EE et al (2005) Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer 104:1620–1626PubMedCrossRefGoogle Scholar
  20. 20.
    Cerfolio RJ, Bryant AS (2006) Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg 82:391–394PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Valentina Ambrosini
  • Maria Cristina Marzola
  • Paola Caroli
  • Stefano Fanti
  • Domenico Rubello
    • 1
  1. 1.Dept. of Nuclear Medicine“Santa Maria della Misericordia” HospitalRovigoItaly

Personalised recommendations